PT Novell

PT Novell Pharmaceutical Laboratories is a leading Indonesian pharmaceutical company established in 1998 that specializes in the development, manufacturing, and marketing of a broad range of healthcare products. The company operates state-of-the-art manufacturing facilities that have earned international certifications from the Australian TGA, South African MCC, and European Union GMP, facilitating its expansion into global export markets. Novell's diverse portfolio includes branded generics, over-the-counter medicines, and a growing pipeline of biosimilars targeting oncology and metabolic diseases. It is recognized as one of the first Indonesian companies to receive international GMP approval for its production plants, including dedicated facilities for cytotoxic and sterile products. Through strategic investments and a focus on R&D, Novell has positioned itself as a key player in the Southeast Asian pharmaceutical landscape, offering both proprietary products and contract manufacturing services.